Subsequent Events |
6 Months Ended |
|---|---|
Apr. 30, 2025 | |
| Subsequent Events [Abstract] | |
| Subsequent Events | Subsequent event On May 28, 2025 the Company signed an agreement to divest select product lines within its medical contract manufacturing business. Expected to close in the fourth quarter fiscal 2025, this deal will allow the Company to focus on achieving above-market growth in its proprietary medical components, including devices from the recent Atrion acquisition. The Company does not anticipate any material impact on the consolidated financial statements.
|